Not only completed but continues as an open label study which implies good tolerance and patient motivation to continue taking the drug. Flo, When can we expect the results to be presented or published? If positive the demand for more drug will help our bottom line as a phase III trial will need lots of product. bp
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.